• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Episode 6 - Pharmacotherapy Versus Bariatric Surgery

Video

Substantial and sustained weight loss results in improvements in obesity-related comorbidities, and clinicians may consider pharmacotherapy and/or bariatric surgery in appropriate patients. Peter Salgo, MD, comments that bariatric surgery is a more expensive option compared with pharmacotherapy.

Although pharmacotherapy may be less expensive, Yehuda Handelsman, MD, FACP, FACE, FNLA, notes that surgery is a first-choice option for many patients, especially for patients who have a body mass index of 35 or greater and need to lose a larger proportion of weight very quickly.

Maria Lopes, MD, MS, explains that in order to evaluate the financial benefits of pharmacotherapy and bariatric surgery, comparative effectiveness data are needed. Even more important, Dr Lopes states, are data to show that pharmacotherapy options are truly effective.

Jeffrey D. Dunn, PharmD, MBA, comments that because treating obesity is expensive, key stakeholders in healthcare need to figure out how to better spend the limited resources currently available for the management of obesity.

Together, Kari Uusinarkaus, MD, FAAFP, FNLA, and Drs Handelsman and Lopes conclude that a multi-stakeholder approach, with help from the government, is necessary. Dr Handelsman adds that because obesity is so expensive, prevention programs are essential.


Related Videos
James Robinson, PhD, MPH, University of California, Berkeley
James Robinson, PhD, MPH, University of California, Berkeley
James Robinson, PhD, MPH, University of California, Berkeley
Carrie Kozlowski
James Robinson, PhD, MPH, University of California, Berkeley
Carrie Kozlowski, OT, MBA
Miriam J. Atkins, MD, FACP, president of the Community Oncology Alliance (COA) and physician and partner of AO Multispecialty Clinic in Augusta, Georgia.
Carrie Kozlowski, OT, MBA
Shawn Gremminger
Dr Lucy Langer
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.